Suspected Neutropenic Enterocolitis
Abdominal symptoms in neutropenic patient
All Pathways
Hematology & OncologyEmergency
Neutropenic Enterocolitis (Typhlitis) Management
Neutropenic Enterocolitis (Typhlitis) Management: Suspected Neutropenic Enterocolitis → Recognize Clinical Triad → Identify Risk Factors → Obtain CT Abd...
Pathway Overview
12 steps
Algorithm Steps
12 total
01Start 02Action Recognize Clinical Triad
Classic presentation
- 1. NEUTROPENIA: ANC <500/μL
- (often profound <100)
- 2. FEVER: Temperature ≥38°C
- 3. ABDOMINAL PAIN:
- • Right lower quadrant (cecum)
- • May be diffuse
- • Cramping, tenderness, distension
- OTHER: Diarrhea (often bloody), nausea/vomiting
03Action Identify Risk Factors
Who develops typhlitis
- HIGH RISK:
- • AML induction chemotherapy
- • High-dose cytarabine
- • Taxanes (docetaxel, paclitaxel)
- • HSCT conditioning
- • Aplastic anemia treatment
- TIMING: Usually during nadir (7-14 days post-chemo)
- Incidence: 5-10% in hematologic malignancy
04Action Obtain CT Abdomen/Pelvis
Imaging is key to diagnosis
- CT WITH IV CONTRAST (if renal function allows)
- DIAGNOSTIC FINDINGS:
- • Bowel wall thickening ≥4mm
- • Most common: cecum, ascending colon, terminal ileum
- • Pericolonic fat stranding
- • Intramural gas (pneumatosis - severe)
- • Ascites
- RULE OUT: Perforation, abscess, appendicitis
05Decision Assess Severity
Guides management approach
- MILD-MODERATE:
- • Bowel wall 4-10mm
- • No perforation/abscess
- • Hemodynamically stable
- SEVERE:
- • Bowel wall >10mm
- • Pneumatosis intestinalis
- • Perforation or abscess
- • Septic shock
- • Peritonitis
06Action Conservative Management
Most cases managed medically
- 1. NPO (bowel rest)
- 2. NG tube if significant distension/vomiting
- 3. IV fluids and electrolyte replacement
- 4. TPN if prolonged bowel rest expected
- 5. Broad-spectrum antibiotics:
- • Piperacillin-tazobactam 4.5g IV q6h OR
- • Meropenem 1g IV q8h
- • ADD Vancomycin if hemodynamically unstable
- • ADD Metronidazole for anaerobes
- 6. G-CSF to shorten neutropenia
07Action Rule Out C. difficile
Common coexisting infection
- C. diff testing on stool (PCR or toxin)
- May coexist with typhlitis
- If positive: Add oral vancomycin 125mg QID
- Avoid antimotility agents
- Fidaxomicin alternative
08Action Close Monitoring
Serial assessments
- Serial abdominal exams q4-6h
- Daily CBC, BMP, lactate
- Repeat CT if clinical deterioration
- Watch for: increasing distension, peritonitis, shock
- Most improve within 5-7 days as ANC recovers
09Decision Surgical Consultation Needed?
Indications for surgical intervention
- ABSOLUTE INDICATIONS:
- • Free perforation with peritonitis
- • Uncontrolled GI bleeding
- • Clinical deterioration despite medical therapy
- RELATIVE INDICATIONS:
- • Abscess requiring drainage
- • Persistent sepsis despite antibiotics
- • Bowel necrosis on imaging
- HIGH MORTALITY: Surgery in neutropenic patients ~50%
10Action Surgical Intervention
When conservative management fails
- Right hemicolectomy most common
- Diverting ileostomy may be needed
- High morbidity/mortality in neutropenic patients
- Delay if possible until ANC recovering
- G-CSF perioperatively
11Action Recovery & Diet Advancement
As neutropenia resolves
- Advance diet slowly as symptoms improve
- Clear liquids → low residue → regular
- Continue antibiotics until afebrile + ANC >500
- Future chemotherapy: consider dose reduction
- Recurrence possible with subsequent cycles
12Outcome Typhlitis Resolved
Plan for future chemotherapy cycles
- Path rejoins step 11Shared downstream outcome
- Path rejoins step 09Shared downstream outcome
Guideline Source
Neutropenic Enterocolitis: Clinical Evidence and Management
Clinical Safety Information
Clinical Decision Support — Not a Substitute for Clinical Judgment
Individual patient factors may require deviation from these recommendations.
Known Limitations
- Diagnostic criteria not universally standardized
- Surgical thresholds vary by institution
- Limited prospective data on management
- May be confused with C. diff or other colitides
Applicable Regions
USEU
Version 1Next review: 2027-01-11
Next steps
Finish the workflow by opening the most relevant calculator, then convert the session into a live account when you are ready.
Calculator
Absolute Neutrophil Count (ANC)
Absolute neutrophil count from CBC for neutropenia grading
Open page
Compare
AttendMe.ai vs OpenEvidence
See how this pathway workflow compares against OpenEvidence.
Open page
Commercial
Start free
Run the pathway in a live AttendMe account with citations and tracked usage.
Start free
Related Resources
Frequently Asked Questions
What is the Neutropenic Enterocolitis (Typhlitis) Management?
The Neutropenic Enterocolitis (Typhlitis) Management is a emergency clinical algorithm for Hematology & Oncology. It provides a structured decision tree to guide clinical decision-making, based on Neutropenic Enterocolitis: Clinical Evidence and Management.
What guideline is the Neutropenic Enterocolitis (Typhlitis) Management based on?
This algorithm is based on Neutropenic Enterocolitis: Clinical Evidence and Management (DOI: 10.1148/rg.2019180097).
What are the limitations of the Neutropenic Enterocolitis (Typhlitis) Management?
Known limitations include: Diagnostic criteria not universally standardized; Surgical thresholds vary by institution; Limited prospective data on management; May be confused with C. diff or other colitides. Individual patient factors may require deviation from these recommendations.
Get AI-Powered Analysis Alongside This Algorithm
In AttendMe.ai, the Neutropenic Enterocolitis (Typhlitis) Management appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.
Try AttendMe Free